Header Logo

Connection

Stephen Jensik to Middle Aged

This is a "connection" page, showing publications Stephen Jensik has written about Middle Aged.
Connection Strength

0.054
  1. Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
    View in: PubMed
    Score: 0.021
  2. Arteriovenous fistula patency in the 3?years following vonapanitase and placebo treatment. J Vasc Surg. 2017 Apr; 65(4):1113-1120.
    View in: PubMed
    Score: 0.017
  3. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. Transplantation. 2005 Aug 15; 80(3):303-9.
    View in: PubMed
    Score: 0.008
  4. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clin Transplant. 2005 Feb; 19(1):130-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.